If you have traveled to any area in the US that is considered a “hot spot” with increasing amount of cases of COVID please alert our office before coming in for any appointment. All VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Archive

Post Archive: Alex Spira MD PhD FACP

Interview with Dr. Alex Spira - Medpage Today Lung Cancer and Covid19

June 16, 2020
Read More

Virginia Cancer Specialists Investigators Neelima Denduluri, MD & Alex Spira, MD, PhD, FACP Present Data Highlighting Key Advances in Oncology Research - 2020 ASCO Annual Meeting & Expo

May 28, 2020
Read More

Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial

April 9, 2020
Read More

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

April 2, 2019
Read More

Virginia Cancer Specialists (VCS) Now Offering a Newly FDA-Approved Targeted Therapy for Acute Leukemia

February 4, 2019
Read More

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

October 8, 2018
Read More

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

September 25, 2018
Read More

Alex Spira, M.D., PhD, F.A.C.P. receives award for his work in Lung Cancer

September 20, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

May 22, 2018
Read More

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

April 26, 2018
Read More